This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Exonhit Therapeutics, Sa. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Richard Einstein: Innovator in Prostate Cancer Therapy
Introduction
Richard Einstein is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer research, particularly in the area of prostate cancer therapy. His work focuses on identifying specific genes that can be targeted for treatment, diagnosis, or prevention of prostate cancer.
Latest Patents
Richard Einstein holds a patent titled "Prostate specific genes and the use thereof as targets for prostate cancer therapy." This patent identifies genes that are upregulated in human prostate tumor tissues, along with the corresponding proteins. These genes and their antigens are recognized as suitable targets for advancing prostate cancer treatment.
Career Highlights
Richard Einstein is associated with Exonhit Therapeutics, a company dedicated to developing innovative solutions in cancer therapy. His expertise in molecular biology and genetics has positioned him as a key figure in the research community.
Collaborations
Throughout his career, Richard has collaborated with esteemed colleagues, including Matthew P. Pando and Kevin M. McGowan. These partnerships have enhanced the research efforts in the field of prostate cancer.
Conclusion
Richard Einstein's contributions to prostate cancer therapy through his innovative patent and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatment options for patients facing this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile